Company news

Vor Biopharma Inc. news in 2021

Vor Biopharma Inc.'s news releases, calls and decks from 2021, newest first.

View company

Vor Reports Third Quarter 2021 Financial Results and Provides Company Update

November 9, 2021

Vor to Present New Data on its Cell and Genome Engineering Platform at SITC Annual Meeting

November 8, 2021

Vor Strengthens Leadership Team with Addition of Dr. Veit Schmelmer as SVP of Program and Alliance Management

October 11, 2021

VOR33 Granted U.S. FDA Fast Track Designation for AML

September 8, 2021

Vor Reports Second Quarter 2021 Financial Results and Provides Company Update

August 8, 2021

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

July 7, 2021

Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs

June 16, 2021

Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

June 10, 2021

Vor to Develop Multi-Targeted CAR-Ts with Abound Bio

June 9, 2021

Vor Reports First Quarter 2021 Financial Results and Provides Company Update

May 5, 2021

Vor Reports Fiscal Year 2020 Financial Results

March 24, 2021

Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference

February 28, 2021

Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares

February 8, 2021

Vor Biopharma Announces Pricing of Initial Public Offering

February 4, 2021

Decks in 2021